U.S. Markets close in 3 hrs, 16 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,401.75 | -49.20 | -0.47% |
| NASDAQ | 2,163.93 | -12.08 | -0.56% |
| S&P 500 | 1,102.57 | -3.67 | -0.33% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 3.90 09:30 AM EST | |
|---|---|---|
| Day High | 4.08 12:15 PM EST |
|
| Range | 0.18 |
| Volume | 88,870 | |
|---|---|---|
| 30-Day Avg Vol | 262,000 |
|
| Difference | -66.08% |
| Market Cap | 236.36 M | |
|---|---|---|
| Mkt Cap Chg | 4.64 M |
| Shares Out | 58.07 M | |
|---|---|---|
| % Shrs Traded | 0.15% | |
| 1yr EPS Est | 0.433 |
| 52-Wk Low | 1.05 | |
|---|---|---|
| 52-Wk High | 4.23 |
|
| Range | 3.18 |
| Prev Close | 3.99 11/23/09 | |
|---|---|---|
| Today's Open | 4.00 | |
| Change | 0.25% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 1.72 M |
| Revenue (LFY) | 130.20 M | |
|---|---|---|
| Earnings (LFY) | -18.52 M | |
| Earnings (MRQ) | 5.34 M | |
| Next Earn Est | 0.163 | |
| Next Earnings | 03/01/2010 |
|
| EPS (TTM) | -0.06 | |
| 1yr EPS Growth | 209.29% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | 9.40 | |
| PEG Ratio | 0.85 | |
| Return on Equity | -156.39 | |
| Beta | 0.90 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Santarus targets more than a little tummy ache. The company's flagship drug Zegerid is a modified version of omeprazole, the proton pump inhibitor (PPI) found in AstraZeneca's best-selling Prilosec. Zegerid ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.163 3/1/10 | — — |
—
—
|
| Last Quarter | -0.01 9/30/09 | 0.09 9/30/09 |
0.10
Beat
|
| 2 Quarters Ago | 0.00 6/30/09 | 0.02 6/30/09 |
0.02
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 39.45 M | 130.20 M |
| Gross Profit | 35.43 M | 100.60 M |
| Operating Income | 5.66 M | -19.17 M |
| Net Income | 5.34 M | -18.52 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts